BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.

Andere Sprachen Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

Aktien

603392

CNE100004090

603392

Schlusskurs Shanghai S.E. Andere Börsenplätze 00:00:00 16.05.2024			% 5 Tage	% 1. Jan.
65,93 ^CNY	-0,15 %		-3,48 %	-12,25 %

25.04.	Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. meldet Ergebnis für das erste Quartal bis zum 31. März 2024	CI
29.03.	Wantai BioPharm's 2023 Gewinn fällt um 74% auf Umsatzrückgang; Aktien brechen um 3% ein	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	25.04.
Wantai Biological's Phase 3 Trials for Nine-Valent HPV Vaccine Yields Performed 'As Expected'	12.04.
Wantai BioPharm's 2023 Profit Drops 74% on Revenue Drop; Shares Slump 3%	29.03.
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	28.03.
Wantai Biological Pharmacy Predicts Up to 75% Profit Decline in 2023	25.01.
Sinovac Halts Production of COVID-19 Vaccine as Demand Wanes	12.01.
Zhifei Biological Falls After Merck Secures Nod to Market HPV Vaccine in China	11.01.
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	27.10.23
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. announces an Equity Buyback for CNY 400 million worth of its shares.	23.09.23
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. authorizes a Buyback Plan.	28.08.23
Wantai Biological Pharmacy's Profit Drops 36.8% in H1	25.08.23
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	24.08.23
Wantai Biological Pharmacy’s Profit Slides 6.5% in Q1 as Revenue Falls 9%	21.04.23
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	20.04.23
Wantai BioPharm Enrolls First Subjects for Pneumonia Vaccine Trial	14.02.23
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	19.01.23
Tranche Update on Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.'s Equity Buyback Plan announced on August 6, 2022.	23.12.22
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.'s Equity Buyback announced on August 6, 2022, has expired with 1,585,320 shares, representing 0.17% for CNY 200.17 million.	21.12.22
Las acciones chinas revierten las ganancias iniciales y terminan a la baja por tercera sesión -- Market Talk	14.12.22
China's super-rich see fortunes plunge as economy slows	08.11.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

Aktien

603392

CNE100004090

603392

Andere Sprachen

Filter